APAC Much of the global pharma industry is talking about disruption, but Brendan Shaw, founder of Shawview Consulting and adjunct professor at the University of Sydney, has found a different mood in Asia Pacific: optimism. With Asia now accounting for about 43 percent of the global innovative pipeline and Western pharma…
Turkey Innovative medicines can take five to ten years to reach patients in emerging markets, if they arrive at all. Since 2013, Inpharmus has worked to close that gap, commercialising oncology and rare disease therapies for biotech and pharma partners across the Middle East, North Africa, Türkiye, and CIS. CEO İsmet…
MEA Swiss market expansion group DKSH has agreed to buy NewBridge Pharmaceuticals, a Dubai-based company that commercialises specialty and rare disease medicines across the Middle East and North Africa, for USD 390 million. PharmaBoardroom has followed NewBridge closely since its early years, interviewing CEO Joe Henein four times since 2013,…
Korea Dr Jai Jun Choung, CEO of AriBio, discusses the company’s integrated approach to neurodegenerative disease, combining AI-driven network biology, polypharmacology and prevention to develop therapies for Alzheimer’s and related disorders. He outlines the progress of lead candidate AR1001, the broader pipeline, strategic partnerships, and Korea’s biotech ecosystem, while emphasising patient-centred…
France We need to raise our voice and say: look at us too, there are also mid-sized pharma companies out there looking for something different In conversation at BIO 2026 in San Diego, Frédéric Scaerou, Head of Global Business Development at Servier, explains why the company is staying disciplined rather than…
Europe Over three decades at Terumo, Takuya Hosogai has seen the Group evolve across businesses, markets and technologies. Now leading Terumo Europe, he discusses the region’s growing role in Pharmaceutical Solutions alongside its established interventional business, and how closer pharma partnerships, continuous innovation and a deeply rooted culture are shaping its…
Europe The science only matters if we can bring those therapies to the people who need them As ophthalmology enters a new era shaped by aging populations, childhood myopia and medical advances, the role of healthcare companies is evolving. For Marianthi Psaha, President and Head of EMEA and International Pricing, Market…
Korea Multi-million dollar deals, world-first approvals, and a new willingness to be patient are transforming how Korea’s biotech sector does business. Korean biotech companies want to hold onto their molecules for longer. That was the message from nearly every biotech executive PharmaBoardroom spoke with in a series of recent interviews in…
Taiwan Dr Yuan-Hung Hsu, President of MegaPro Biomedical, discusses the Taiwanese company’s evolution into a late-stage nanomedicine company, with two platforms targeting precision medicine. He highlights MPB 1523, a heavy-metal-free MRI contrast agent for liver cancer, and MPT 1734, a nanomicelle-based therapy for prostate cancer, while outlining MegaPro’s partnership strategy, cell-tracking…
Korea James Park discusses Lotte Biologics’ strategy to establish itself as a global CDMO through dual manufacturing hubs in the US and Korea, advanced biologics and ADC capabilities, and a strong service-oriented culture. He outlines the company’s expansion plans, technological differentiation, and support for Korea’s emerging biotech ecosystem, while reflecting on…
UAE It takes a great deal to become number one in a field, but the harder challenge is staying there Joe Henein, CEO of Dubai-headquartered NewBridge Pharmaceuticals, has built one of MENA’s most distinctive specialty pharma platforms over the past 15 years. With over 300 people across MENA, a pan-regional footprint…
UK Drawing on a career spanning oncology drug discovery at AstraZeneca and biotech leadership as CEO of Enhanc3d Genomics, Hazel Jones is now Chief Strategy Officer at Laverock Therapeutics. We caught up with her at the Asia Summit on Global Health in Hong Kong, where the company was showcasing its programmable…
See our Cookie Privacy Policy Here